New Delhi: India has less than five states where the number of active COVID-19 cases is beyond 50,000, while at least 14 states and Union Territories have less than 5,000 active cases of the viral disease, the Union Health Ministry said on Tuesday evening.
The country’s average positivity rate is 8.4 per cent, the ministry stated. Also Read – ‘I Am With BJP-RSS Now, Will Control ‘Goondagardi’ Says Ex-Navy Officer Madan Sharma Who Was Attacked by Shiv Sena
“The US & countries of Europe had a peak, then they came down&there is a 2nd wave occurring there. We took learning from that. We distributed the curve in a way that we didn’t have many deaths. It was because we had an effective lockdown. We didn’t have a huge peak at all,” said ICMR DG Dr Balram Bhargava.
Addressing the current status of COVID-19 vaccine in India, the health ministry said that three vaccines are already at the clinical trial stage in the country.
“Cadila and Bharat Biotech have completed phase-I trials. Serum Institute has completed phase II-B3 trials, and will start phase-III trial (with 1500 patients at 14 locations) after clearances,” the Bhargava noted.
The Health Ministry also said that a constant study is being conducted to find out the extent to which plasma therapy helps in treating COVID-19 infection.